Mortality, Morbidity and Healthcare Expenditures After Local Tumour Ablation or Partial Nephrectomy For T1a Kidney Cancer

Abstract Background Local tumour ablation (LTA) may yield better perioperative outcomes than partial nephrectomy (PN), however the impact of each treatment on perioperative mortality and health care expenditures is unknown. The aim of the study was to compare mortality, morbidity and health care exp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2017-04, Vol.43 (4), p.815-822
Hauptverfasser: Larcher, Alessandro, MD, Sun, Maxine, BSc, Dell’Oglio, Paolo, MD, Trudeau, Vincent, MD, Boehm, Katharina, MD, Schiffmann, Jonas, MD, Tian, Zhe, BSc, Fossati, Nicola, MD, Capitanio, Umberto, MD, Briganti, Alberto, Montorsi, Francesco, Karakiewicz, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Local tumour ablation (LTA) may yield better perioperative outcomes than partial nephrectomy (PN), however the impact of each treatment on perioperative mortality and health care expenditures is unknown. The aim of the study was to compare mortality, morbidity and health care expenditures between LTA and PN. Patients and Methods A population based assessment of 2471 patients with cT1a kidney cancer treated with either LTA or PN, between 2000 and 2009, in the SEER–Medicare database was performed. After propensity score matching, 30-day mortality, overall and specific complication rates, length of stay, readmission rates and health care expenditures according to LTA or PN were estimated. Multivariable logistic and linear models addressed the effect of each specific LTA approach on overall complication rates, length of stay, readmission rates and health care expenditures. Results The 30-day mortality was
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2016.08.023